These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 19589877)

  • 1. Multi-domain misfolding: understanding the aggregation pathway of polyglutamine proteins.
    Saunders HM; Bottomley SP
    Protein Eng Des Sel; 2009 Aug; 22(8):447-51. PubMed ID: 19589877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The structural impact of a polyglutamine tract is location-dependent.
    Robertson AL; Horne J; Ellisdon AM; Thomas B; Scanlon MJ; Bottomley SP
    Biophys J; 2008 Dec; 95(12):5922-30. PubMed ID: 18849414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The rate of polyQ-mediated aggregation is dramatically affected by the number and location of surrounding domains.
    Robertson AL; Bate MA; Buckle AM; Bottomley SP
    J Mol Biol; 2011 Nov; 413(4):879-87. PubMed ID: 21945530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analyzing the aggregation of polyglutamine-expansion proteins and its modulation by molecular chaperones.
    Kubota H; Kitamura A; Nagata K
    Methods; 2011 Mar; 53(3):267-74. PubMed ID: 21195182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PolyQ fibrillation in the cell nucleus: who's bad?
    von Mikecz A
    Trends Cell Biol; 2009 Dec; 19(12):685-91. PubMed ID: 19796946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyglutamine expansion mutation yields a pathological epitope linked to nucleation of protein aggregate: determinant of Huntington's disease onset.
    Sugaya K; Matsubara S; Kagamihara Y; Kawata A; Hayashi H
    PLoS One; 2007 Jul; 2(7):e635. PubMed ID: 17653262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular chaperones as modulators of polyglutamine protein aggregation and toxicity.
    Sakahira H; Breuer P; Hayer-Hartl MK; Hartl FU
    Proc Natl Acad Sci U S A; 2002 Dec; 99 Suppl 4(Suppl 4):16412-8. PubMed ID: 12189209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyglutamine induced misfolding of huntingtin exon1 is modulated by the flanking sequences.
    Lakhani VV; Ding F; Dokholyan NV
    PLoS Comput Biol; 2010 Apr; 6(4):e1000772. PubMed ID: 20442863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of ataxin-3 misfolding and fibril formation: kinetic analysis of a disease-associated polyglutamine protein.
    Ellisdon AM; Pearce MC; Bottomley SP
    J Mol Biol; 2007 Apr; 368(2):595-605. PubMed ID: 17362987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p97 Homologs from Caenorhabditis elegans, CDC-48.1 and CDC-48.2, suppress the aggregate formation of huntingtin exon1 containing expanded polyQ repeat.
    Nishikori S; Yamanaka K; Sakurai T; Esaki M; Ogura T
    Genes Cells; 2008 Aug; 13(8):827-38. PubMed ID: 18782221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flanking domain stability modulates the aggregation kinetics of a polyglutamine disease protein.
    Saunders HM; Gilis D; Rooman M; Dehouck Y; Robertson AL; Bottomley SP
    Protein Sci; 2011 Oct; 20(10):1675-81. PubMed ID: 21780213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface plasmon resonance characterization of specific binding of polyglutamine aggregation inhibitors to the expanded polyglutamine stretch.
    Okamoto Y; Nagai Y; Fujikake N; Akiko Popiel H; Yoshioka T; Toda T; Inui T
    Biochem Biophys Res Commun; 2009 Jan; 378(3):634-9. PubMed ID: 19061859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggregation of polyglutamine-expanded ataxin-3 sequesters its specific interacting partners into inclusions: implication in a loss-of-function pathology.
    Yang H; Li JJ; Liu S; Zhao J; Jiang YJ; Song AX; Hu HY
    Sci Rep; 2014 Sep; 4():6410. PubMed ID: 25231079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the structure and the amyloidogenic properties of the Josephin domain of the polyglutamine-containing protein ataxin-3.
    Masino L; Nicastro G; Menon RP; Dal Piaz F; Calder L; Pastore A
    J Mol Biol; 2004 Dec; 344(4):1021-35. PubMed ID: 15544810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HSPB7 is the most potent polyQ aggregation suppressor within the HSPB family of molecular chaperones.
    Vos MJ; Zijlstra MP; Kanon B; van Waarde-Verhagen MA; Brunt ER; Oosterveld-Hut HM; Carra S; Sibon OC; Kampinga HH
    Hum Mol Genet; 2010 Dec; 19(23):4677-93. PubMed ID: 20843828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticle-induced cell culture models for degenerative protein aggregation diseases.
    Chen M; von Mikecz A
    Inhal Toxicol; 2009 Jul; 21 Suppl 1():110-4. PubMed ID: 19558242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mimicking proteasomal release of polyglutamine peptides initiates aggregation and toxicity.
    Raspe M; Gillis J; Krol H; Krom S; Bosch K; van Veen H; Reits E
    J Cell Sci; 2009 Sep; 122(Pt 18):3262-71. PubMed ID: 19690053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteome analysis of soluble nuclear proteins reveals that HMGB1/2 suppress genotoxic stress in polyglutamine diseases.
    Qi ML; Tagawa K; Enokido Y; Yoshimura N; Wada Y; Watase K; Ishiura S; Kanazawa I; Botas J; Saitoe M; Wanker EE; Okazawa H
    Nat Cell Biol; 2007 Apr; 9(4):402-14. PubMed ID: 17384639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aggregate-prone proteins are cleared from the cytosol by autophagy: therapeutic implications.
    Williams A; Jahreiss L; Sarkar S; Saiki S; Menzies FM; Ravikumar B; Rubinsztein DC
    Curr Top Dev Biol; 2006; 76():89-101. PubMed ID: 17118264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring polyglutamine toxicity in yeast.
    Duennwald ML
    Methods; 2011 Mar; 53(3):232-7. PubMed ID: 21144902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.